Cargando…
Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes
BACKGROUND: Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in development...
Autores principales: | Huang, Zhe, Klaric, Lucija, Krasauskaite, Justina, McLachlan, Stela, Strachan, Mark W. J., Wilson, James F., Price, Jackie F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047374/ https://www.ncbi.nlm.nih.gov/pubmed/35477395 http://dx.doi.org/10.1186/s12933-022-01493-w |
Ejemplares similares
-
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes
por: Sandoval-Garcia, Emmanuel, et al.
Publicado: (2021) -
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
por: Feinkohl, Insa, et al.
Publicado: (2015) -
Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study
por: Price, Anna H., et al.
Publicado: (2017) -
Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study
por: Sluiman, Anniek J., et al.
Publicado: (2021) -
Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation
por: Carr, Alistair L., et al.
Publicado: (2020)